CTCLAG

The Cellular Therapy Coding and Labeling Advisory Group was established in 2004.  Its purpose is to advise ICCBBA of the needs of cellular therapy organizations for coding and labeling.  Membership comprises representatives from major cellular therapy professional organizations:  AABB, APBMT, ASBMT, ASFA, EBMT, FACT, ISBT, ISCT, JACIE, NMDP and WMDA.  Additionally, the group has invited technical experts to serve as voting members on the group.

Liaisons from other organizations, primarily representing regulatory bodies, also attend meetings. 

Vendors and other interested parties attend meetings as observers at the discretion of the chairman.

The CTCLAG meets bimonthly by conference call and once annually face-to-face.

Many facilities are currently using ISBT 128 terminology because it is required by the Standards of AABB, FACT and JACIE.  The group is currently encouraging facilities to fully implement ISBT 128, including label design and bar codes.

The group routinely reviews requests for product codes that require new classes, modifiers, and attributes.  An area of active discussion is the coding of products such as menstrual cells.

Member

• Ineke Slaper-Cortenbach (JACIE), Chair
• Sallie Allman (NMDP)
• Paul Ashford (ICCBBA)
• Boris Calmels (Technical Expert)

• Giovanna Cameron (Technical Expert)

• Pat Distler (ICCBBA), Secretary
• William Janssen (ASBMT)
• Mickey Koh (APBMT)
• Alan Lankester (Technical Expert)
• Stella Larsson (Technical Expert)
• Kathy Loper (AABB)
• John Miller (WMDA)
• Sergio Querol (EBMT)
• Leigh Sims Poston (ISCT)
• Zbigniew Szczepiorkowski (ASFA)
• Daphne Thijssen-Timmer (ISBT)
• Phyllis Warkentin (FACT)

Liaisons

• Mona Hansson (The National Board of Health and Welfare)
• Ellen Lazarus (US FDA)